Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients.

Cascella NG, Santora D, Gregory P, Kelly DL, Fasano A, Eaton WW.

Schizophr Bull. 2013 Jul;39(4):867-71. doi: 10.1093/schbul/sbs064. Epub 2012 Apr 19.

2.

Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis.

Sestak K, Mazumdar K, Midkiff CC, Dufour J, Borda JT, Alvarez X.

J Vis Exp. 2011 Dec 15;(58). pii: 3154. doi: 10.3791/3154.

3.

Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.

Gadoth A, Nefussy B, Bleiberg M, Klein T, Artman I, Drory VE.

JAMA Neurol. 2015 Jun;72(6):676-81. doi: 10.1001/jamaneurol.2015.48.

PMID:
25867286
4.

Gluten sensitivity in patients with IgA nephropathy.

Smerud HK, Fellström B, Hällgren R, Osagie S, Venge P, Kristjánsson G.

Nephrol Dial Transplant. 2009 Aug;24(8):2476-81. doi: 10.1093/ndt/gfp133. Epub 2009 Mar 30.

PMID:
19332868
5.

Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies.

Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H.

J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):276-82.

PMID:
11593122
6.

Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.

Lytton SD, Antiga E, Pfeiffer S, Matthias T, Szaflarska-Poplawska A, Ulaganathan VK, Placek W, Fabbri P, Hall R, Caproni M.

Clin Chim Acta. 2013 Jan 16;415:346-9. doi: 10.1016/j.cca.2012.10.051. Epub 2012 Nov 8.

PMID:
23142793
7.

Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies.

Baudon JJ, Johanet C, Absalon YB, Morgant G, Cabrol S, Mougenot JF.

Arch Pediatr Adolesc Med. 2004 Jun;158(6):584-8.

PMID:
15184223
8.

Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit.

Sugai E, Selvaggio G, Vazquez H, Viola M, Mazure R, Pizarro B, Smecuol E, Flores D, Pedreira S, Mauriño E, Gomez JC, Bai JC.

Am J Gastroenterol. 2000 Sep;95(9):2318-22.

PMID:
11007235
9.

Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.

Vitoria JC, Arrieta A, Arranz C, Ayesta A, Sojo A, Maruri N, García-Masdevall MD.

J Pediatr Gastroenterol Nutr. 1999 Nov;29(5):571-4.

PMID:
10554125
10.

Avidity of antigliadin IgA and IgG antibodies in gluten-sensitive enteropathy and dermatitis herpetiformis.

Vainio E, Collin P, Lehtonen OP.

Clin Immunol Immunopathol. 1986 Nov;41(2):295-300.

PMID:
3769223
11.

Serological tests in gluten sensitivity (nonceliac gluten intolerance).

Volta U, Tovoli F, Cicola R, Parisi C, Fabbri A, Piscaglia M, Fiorini E, Caio G.

J Clin Gastroenterol. 2012 Sep;46(8):680-5. doi: 10.1097/MCG.0b013e3182372541.

PMID:
22138844
12.

Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.

Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, Fasano A, Eaton WW.

Schizophr Bull. 2011 Jan;37(1):94-100. doi: 10.1093/schbul/sbp055. Epub 2009 Jun 3.

13.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

15.

Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?

Shor DB, Barzilai O, Ram M, Izhaky D, Porat-Katz BS, Chapman J, Blank M, Anaya JM, Shoenfeld Y.

Ann N Y Acad Sci. 2009 Sep;1173:343-9. doi: 10.1111/j.1749-6632.2009.04620.x.

PMID:
19758171
16.

Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment.

Sugai E, Nachman F, Váquez H, González A, Andrenacci P, Czech A, Niveloni S, Mazure R, Smecuol E, Cabanne A, Mauriño E, Bai JC.

Dig Liver Dis. 2010 May;42(5):352-8. doi: 10.1016/j.dld.2009.07.011. Epub 2009 Aug 12.

PMID:
19679520
17.

IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy.

Volta U, Molinaro N, Fratangelo D, Bianchi FB.

Dig Dis Sci. 1994 Sep;39(9):1924-9.

PMID:
8082498
18.

Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I.

J Clin Lab Anal. 2009;23(3):165-71. doi: 10.1002/jcla.20313.

PMID:
19455636
19.

Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.

Picarelli A, Sabbatella L, Di TM, Di CT, Vetrano S, Anania MC.

Am J Gastroenterol. 2002 Jan;97(1):95-8.

PMID:
11808976
20.

Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.

Ruuskanen A, Luostarinen L, Collin P, Krekelä I, Patrikainen H, Tillonen J, Laurila K, Haimila K, Partanen J, Mäki M, Valve R, Kaukinen K.

Dig Liver Dis. 2011 Oct;43(10):772-8. doi: 10.1016/j.dld.2011.04.025. Epub 2011 Jun 8.

PMID:
21641886

Supplemental Content

Support Center